gastric-cancer

Documents about gastric-cancer

• Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer#907116ClinicalTrials.gov
• Evaluation of the Efficacy and Safety of Adebrelimab Combined With SOX as Adjuvant Therapy for IIIB and IIIC Gastric Cancer#867559ClinicalTrials.gov
• PD-1 Blockade With JS001 Plus Neoadjuvant Chemotherapy for Gastric/Gastroesophageal Junction Cancer#860077ClinicalTrials.gov
• Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer#887304ClinicalTrials.gov
• A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer#896410ClinicalTrials.gov
• Spanish Registry of Esophagogastric Cancer#287522ClinicalTrials.gov
• Non-gastric Conduit Reconstruction After Esophagectomy#881063ClinicalTrials.gov
• Lifestyle Intervention for Prevention of Gastric Neoplasm#898431ClinicalTrials.gov
• Advanced Gastric Cancer. Results Observed in a Private Regional Health Center#936052Repositorio de Universidad Autónoma de Chile.
• REVOLUTION Surgery (REVOLUTION Surgery)#873485ClinicalTrials.gov
• Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer#826414ClinicalTrials.gov
• [68Ga]Ga-FAPI PET/CT in Gastric and Gastroesophageal Junctional Cancer#846033ClinicalTrials.gov
• Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis#803219ClinicalTrials.gov
• Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer#843074ClinicalTrials.gov
• A Study Evaluating Safety and Pharmacokinetics of FPA144 in Japanese Patients With Advanced Gastric or Gastroesophageal Cancer#849885ClinicalTrials.gov
• Perioperative Chemotherapy for Potentially Resectable Gastric Cancer#851543ClinicalTrials.gov
• Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer#871545ClinicalTrials.gov
• Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer#873371ClinicalTrials.gov
• 3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer#900934ClinicalTrials.gov
• A Non-canonical Wnt Signature Correlates With Lower Survival in Gastric Cancer#948529Repositorio de Universidad Autónoma de Chile.
• Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer#968843ClinicalTrials.gov
• A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer#981755ClinicalTrials.gov
• Phase III Trial of Adjuvant Chemo-radiotherapy After D2 Surgery of Gastric Cancer#992272ClinicalTrials.gov
• Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer#1007364ClinicalTrials.gov
• FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)#1007782ClinicalTrials.gov
• Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours#842364ClinicalTrials.gov
• AI-Based Risk Prediction Model for Upper Digestive Tract Cancer#900744ClinicalTrials.gov
• Volatiles in Breath and Headspace Analysis - Diagnostic Markers#882366ClinicalTrials.gov
• Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.#917238ClinicalTrials.gov
• Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection#865104ClinicalTrials.gov
• Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma#1008148ClinicalTrials.gov
• Neoadjuvant Immunotherapy and Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial#896916ClinicalTrials.gov
• Fast Track Surgery With Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer: a Randomized Controlled Trial#805407ClinicalTrials.gov
• Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer#834059ClinicalTrials.gov
• Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer#845989ClinicalTrials.gov
• RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer#858758ClinicalTrials.gov
• Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer#862717ClinicalTrials.gov
• Nutrition Education Program for Postoperative Patients With Gastric Cancer#865953ClinicalTrials.gov
• Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer#866112ClinicalTrials.gov
• Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)#875190ClinicalTrials.gov
• A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG#879928ClinicalTrials.gov
• Radical Surgery Versus Non-Surgery in Gastric Cancer Patients With Peritoneal Metastasis After Successful Conversion Therapy#910535ClinicalTrials.gov
• Construction and Application of Database of Hebei Provincial Gastric Cancer Collaborative Network Driven by Artificial Intelligence Technology#910935ClinicalTrials.gov
• Indocyanine Green Tracer Using in Laparoscopic Radical Gastrectomy for Locally Advanced Gastric Cancer#912942ClinicalTrials.gov
• TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma#914414ClinicalTrials.gov
• First-line Treatment with RC48 Plus Tislelizumab and S-1(RCTS) in Advanced Gastric Cancer#915983ClinicalTrials.gov
• Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer#917582ClinicalTrials.gov
• Adjuvant chemotherapy for gastric cancer in elderly patients has same benefits as in younger patients#955256Koc University Digital Collections
• Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer#992635ClinicalTrials.gov
• Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)#471455ClinicalTrials.gov